Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.

Gross, Oliver

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. [electronic resource] - Kidney international Mar 2012 - 494-501 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1523-1755

10.1038/ki.2011.407 doi


Adolescent
Adult
Angiotensin-Converting Enzyme Inhibitors--adverse effects
Child
Child, Preschool
Disease Progression
Endpoint Determination
Female
Humans
Infant
Kaplan-Meier Estimate
Kidney--physiopathology
Life Expectancy
Longitudinal Studies
Male
Middle Aged
Nephritis, Hereditary--drug therapy
Renal Insufficiency--mortality
Renal Replacement Therapy
Retrospective Studies
Survival Rate
Treatment Outcome
Young Adult